ASCO GUIDELINES Bundle

Somatic Genomic Testing for Metastatic or Advanced Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475502

Contents of this Issue

Navigation

Page 14 of 15

15 Strength of Recommendations Grade Definition Strong ere is high confidence that the recommendation reflects best practice. is is based on: • strong evidence for a true net effect (e.g., benefits exceed harms); • consistent results, with no or minor exceptions; • minor or no concerns about study quality; and/or • the extent of panelists' agreement. Other compelling considerations (discussed in the guideline's literature review and analyses) may also warrant a strong recommendation. Moderate ere is moderate confidence that the recommendation reflects best practice. is is based on: • good evidence for a true net effect (e.g., benefits exceed harms); • consistent results with minor and/or few exceptions; • minor and/or few concerns about study quality; and/or • the extent of panelists' agreement. Other compelling considerations (discussed in the guideline's literature review and analyses) may also warrant a moderate recommendation. Weak ere is some confidence that the recommendation offers the best current guidance for practice. is is based on: • limited evidence for a true net effect (e.g., benefits exceed harms); • consistent results, but with important exceptions; • concerns about study quality; and/or • the extent of panelists' agreement. Other considerations (discussed in the guideline's literature review and analyses) may also warrant a weak recommendation.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Somatic Genomic Testing for Metastatic or Advanced Cancer